Drugs / DA-5204
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03998969 | Jun 2016 → Dec 2018 | esophageal disorder | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02282670 | Apr → Nov 2014 | chronic gastritis | Dong-A ST Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5204 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02282670 ↗ |
| Route | Oral | “Pantoprazole 40mg once daily and 'DA-5204' twice daily by mouth, administered for 4 weeks” NCT03998969 ↗ |